Gut Microbiome May Help or Hinder Defenses Against SARS-CoV-2

The health of the microbial community is associated with COVID-19 severity, but it’s not yet clear if the relationship is causal.

Written byBianca Nogrady
| 7 min read
elongated blue bacterial cells on a reddish-brown background

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

ABOVE: © ISTOCK.COM, DR_MICROBE

When SARS-CoV-2 first began rampaging around the world, it was thought to primarily affect the respiratory system. It soon became clear that the virus had more far-reaching effects, including on the gastrointestinal system and its bacterial symbionts.

This came as no surprise to Siew Ng, a gastroenterologist in the Center for Gut Microbiota Research at the Chinese University of Hong Kong. “We previously had found quite a lot of impaired gut microbiome in different conditions, including people with infectious disease,” says Ng. COVID-19 patients were no different. “In quite a substantial proportion of people, they also have gut manifestations, such as diarrhea, such as abdominal pain.”

One early study suggested that nearly 20 percent of patients with confirmed SARS-CoV-2 infection had gastrointestinal symptoms. That same study found that COVID-19–infected people shed viral RNA in their feces—another clue that the virus was getting into the gut.

Since ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of smiling woman

    Bianca Nogrady is a freelance science journalist and author who is yet to meet a piece of research she doesn't find fascinating. In addition to The Scientist, her words have appeared in outlets including Nature, The Atlantic, Wired UK, The Guardian, Undark, MIT Technology Review, and the BMJ. She is also author of Climate Change: How We Can Get To Carbon Zero, The End: The Human Experience Of Death, editor of the 2019 and 2015 Best Australian Science Writing anthologies, and coauthor of The Sixth Wave: How To Succeed In A Resource-Limited World. She is based in Sydney, Australia.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies